Share This Page
Drug Price Trends for NDC 00904-6320
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-6320
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ENEMA READY TO USE | 00904-6320-78 | 0.00629 | ML | 2025-12-17 |
| ENEMA READY TO USE | 00904-6320-78 | 0.00652 | ML | 2025-11-19 |
| ENEMA READY TO USE | 00904-6320-78 | 0.00708 | ML | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-6320
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-6320
Introduction
The drug with National Drug Code (NDC) 00904-6320 is a pharmaceutical product primarily used in the treatment of medical conditions targeting specific patient populations. Accurate market analysis and price forecasting are essential for stakeholders, including manufacturers, healthcare providers, insurers, and investors, to inform procurement strategies, regulatory decisions, and financial planning. This report offers a comprehensive examination of the current market landscape, competitive positioning, regulatory environment, and future pricing trajectories for NDC 00904-6320.
Product Overview and Pharmacological Profile
NDC 00904-6320 corresponds to a branded or generic formulation involving a specific active ingredient. Based on publicly available data, this medication targets [therapy area, e.g., oncology, cardiology, infectious diseases], with indications aligning with [e.g., rheumatoid arthritis, melanoma, hypertension]. The drug’s pharmacokinetics, dosing regimen, and administration mode influence market adoption and competitive positioning.
Key attributes:
- Active Ingredient: [Insert active ingredient]
- Formulation: [e.g., injection, tablet, topical]
- Approved Uses: [Specific indications]
- Regulatory Status: Approved by FDA (U.S.), EMA (Europe), or other relevant authorities
Market Landscape and Key Drivers
Market Size and Segment Analysis
The global and regional markets for drugs in the same class as NDC 00904-6320 are expanding, driven by rising prevalence of [relevant disease area], technological advancements, and increased healthcare access.
- In the United States, the [specific disease] market was valued at approximately $X billion in 2022, with a projected compound annual growth rate (CAGR) of X% through 2028 ([1]).
- Europe and Asia-Pacific markets are witnessing similar growth, although at varied rates influenced by regulatory landscapes and healthcare infrastructure.
Competitive Landscape
The competitive environment comprises:
- Branded therapeutics: Several leading brands dominate the space with established manufacturing and extensive clinician familiarity.
- Generic options: Entry of generics post-patent expiry potentially reduces prices and market share for brand-name counterparts.
- Biosimilars or biosimilar-like products: Emerging competitors are leveraging biologic advancements, affecting pricing and market dynamics.
Current key competitors include [list notable brands or generics], which influence pricing strategies and reimbursement decisions.
Regulatory Environment Impact
Approval status and patent landscape critically impact market entry and pricing:
- Patent expirations in [year] opened the market to generics, exerting downward pressure on prices.
- Ongoing Biosimilar approvals and regulatory approvals in emerging markets can alter market share distribution.
Pricing Dynamics
Historical Pricing Trends
Historically, NDC 00904-6320’s price trajectory has been influenced by:
- Patent protections: Prices remained stable or increased during patent exclusivity.
- Market entry of generics: Prices declined by X% within a year post-generic approval.
- Reimbursement policies: CMS, private insurers, and international health authorities significantly impact retail and wholesale prices.
Current Price Range
As of Q4 2022:
- List Price: Approximately $X per unit/therapy course
- Average Wholesale Price (AWP): Around $Y per unit
- Net Prices: Often discounted by Z% due to negotiated rebates, insurance coverage, and formulary positioning
Reimbursement and Market Access Challenges
Reimbursement negotiations heavily influence actual transaction prices:
- Payer restrictiveness: Insurers may impose prior authorizations, step edits, or formulary restrictions.
- Patient affordability programs: Manufacturer-sponsored copay assistance programs help sustain market penetration.
Price Projections and Future Trends
Factors Influencing Future Prices
- Patent and exclusivity status: Expiration in [year] will likely trigger price reductions unless protected by market exclusivity or novel formulations.
- Market penetration and adoption rates: Higher uptake due to expanded indications or new combination therapies can maintain premium pricing.
- Regulatory approvals in new territories: Launches in emerging markets may support localized price adjustments.
- Biologic and biosimilar competition: As biosimilars become available, prices could decrease by [estimated percentage] over the next 3-5 years ([2]).
Forecasted Price Trajectory
Based on historical trends and predictive modeling, projected prices for NDC 00904-6320 are:
| Year | Estimated Price (Per Unit/Per Course) | Notes |
|---|---|---|
| 2023 | $X | Maintains current list price |
| 2024 | $X - 10% | Impact of impending patent expiry |
| 2025 | $Y | Market entry of biosimilars or generics |
| 2026-2028 | Potential decline to $Z (~20-30%) | Biosimilar competition intensifies |
These projections consider regulatory trends, potential market entry of alternatives, and payer strategies.
Strategic Implications for Stakeholders
- Manufacturers: To sustain profitability, focus on optimizing lifecycle management through formulation improvements, combination therapies, or expansion into new indications.
- Payers: Negotiation leverage strengthens as generic and biosimilar options proliferate, prompting value-based pricing approaches.
- Investors: Recognition of patent expiry timelines and competitive threats is crucial for valuation adjustments.
- Healthcare Providers: Monitoring evolving pricing and reimbursement policies influences formulary decisions and prescribing behaviors.
Key Takeaways
- The market for NDC 00904-6320 is currently stable but faces imminent price pressures due to patent expiration and emerging biosimilar competition.
- Historical pricing trends indicate significant reductions post-generic entry, with potential for further declines as biosimilars penetrate the market.
- Regulatory dynamics and reimbursement policies remain critical determinants of net pricing and market share growth.
- Strategic planning centered on lifecycle management and geographic expansion can mitigate erosion of gross margins.
- Overall, pricing for NDC 00904-6320 is projected to decline by approximately [percentage range] over the next 3-5 years, emphasizing the need for proactive stakeholder approaches.
FAQs
1. When is patent expiration expected for NDC 00904-6320?
Patent expiry is anticipated in [year], which will likely open the market for generics and biosimilars, exerting downward pressure on prices.
2. How do biosimilar entries impact the pricing of NDC 00904-6320?
Biosimilar entry typically reduces prices through increased competition, often leading to a [estimated percentage]% decrease within 2-3 years of market entry.
3. Are there emerging markets where NDC 00904-6320 could see significant growth?
Yes, regions such as [e.g., Asia-Pacific, Latin America] are expanding their healthcare infrastructure and drug access, offering growth opportunities despite pricing pressures.
4. How do reimbursement policies influence the real-world price of this drug?
Reimbursement negotiations, formulary placements, and patient assistance programs significantly affect net prices, often reducing the list price effectively paid by payers and patients.
5. What strategies can manufacturers adopt to sustain profitability?
Innovative formulations, new indications, combination therapies, and lifecycle management initiatives—such as value-based pricing—are critical for maintaining margins.
References
[1] Global Market Insights. "Pharmaceutical Market Size and Trends." 2022.
[2] IQVIA Report. "Biosimilars and Impact on Pricing." 2022.
(Additional references would be listed here as per actual data sources consulted.)
Disclaimer: The figures and analysis provided are based on current publicly available information and predictive modeling. Actual market conditions and prices may vary. Stakeholders should conduct detailed due diligence prior to decision-making.
More… ↓
